Insights from the 2025 Honeywell Life Sciences World Tour Axendia participated in the Honeywell Life Sciences World Tour USA. Under the theme “Innovation for a […]
Accelerating Innovation for a Healthier Future Read More »
The FDA is embarking on a transformative journey—one that seeks to modernize regulatory processes, accelerate approvals, and address chronic disease trends in a proactive manner.
Commissioner Unveils Priorities for a New FDA Read More »
An Axendia “Straight from the Source” Episode In the debut episode of Straight from the Source, Axendia’s President Daniel R. Matlis and Senior Industry Analyst, Sandra
The Impact of the Most Favored Nation Pricing Executive Order Read More »
An Apprentice.io Briefing Note Axendia was briefed by the executive team at Apprentice.io, including Angelo Stracquatanio, CEO and Co-Founder, Emilee Cook, VP of Product, Justin
The Expanding Role of Agentic AI Connected Manufacturing Read More »
ComplianceQuest ConQuest 2025 Event Brief ComplianceQuest held its second annual user conference (ConQuest 2025) in Clearwater, FL from 8-10 April 2025. This year’s theme was
Where Compliance Meets Innovation: A New Chapter Unfolds at ConQuest Read More »
On May 8, 2025, the U.S. Food and Drug Administration (FDA) announced a historic milestone: the completion of its first AI-assisted scientific review pilot. Additionally,
From Pilot to Policy: FDA’s AI Transformation Hits Fast Forward Read More »
On May 5, 2025, an executive order titled “Regulatory Relief to Promote Domestic Production of Critical Medicines“ was signed by the administration. The order seeks
Strengthening Domestic Pharmaceutical Manufacturing in the Age of Continuous Disruption Read More »
Stellix Aspire 2025 Event Brief Axendia was pleased to be invited to cover Stellix Aspire 2025, an exclusive event where thought leaders and executives gathered to advance
Innovation, Collaboration, Acceleration Read More »
From Simple Prompts to Autonomous Systems Artificial intelligence is driving a significant transformation in quality management. Quality management is evolving from basic command-based interactions into
The Evolution of AI in Quality Management Read More »
Life Sciences Strategies for Adapting Under Dr. Marty Makary’s Leadership in 2025 and Beyond! As a Sr. Industry Analyst who closely tracks the pulse of
The FDA’s New Chapter Read More »
We define “The Age of Continuous Disruption” as a series of interconnected and overlapping challenges, including natural disasters, geopolitical developments, and shifting trade policies, that
Turning Trade Challenges into Opportunities for Life Sciences Read More »
Axendia’s 7th Annual Life Sciences Industry Radar – “Straight from the Source (SftS) Event“ Axendia unveiled its 7th annual Life Sciences Industry Radar in the
Continuous Innovation and Improvement – The Cornerstone for Resilience Read More »
